AbbVie Inc. (FRA:4AB)
Germany · Delayed Price · Currency is EUR | Market Cap | 342.11B |
| Revenue (ttm) | 50.83B |
| Net Income (ttm) | 2.00B |
| Shares Out | n/a |
| EPS (ttm) | 1.13 |
| PE Ratio | 170.95 |
| Forward PE | 16.48 |
| Dividend | 5.86 (3.06%) |
| Ex-Dividend Date | Oct 15, 2025 |
| Volume | 37 |
| Average Volume | 66 |
| Open | 189.20 |
| Previous Close | 190.00 |
| Day's Range | 189.20 - 191.20 |
| 52-Week Range | 147.00 - 209.50 |
| Beta | n/a |
| RSI | 44.82 |
| Earnings Date | Jan 30, 2026 |
About AbbVie
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancer... [Read more]
Financial Performance
In 2024, AbbVie's revenue was $56.33 billion, an increase of 3.71% compared to the previous year's $54.32 billion. Earnings were $4.24 billion, a decrease of -12.07%.
Financial numbers in USD Financial StatementsNews
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
As big pharmaceutical companies are set to finalize a deal with the U.S. government to bring down prices for some prescription drugs, another old question is coming into focus for investors: how much ...
Trump to announce new drug-pricing deals later today
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
AbbVie (ABBV) and Others to Announce U.S. Drug Price Cuts
AbbVie (ABBV) and Others to Announce U.S. Drug Price Cuts
AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead (GILD), and Merck (MRK) are set to annouce U.S. drug pricing deals. Read more here.
Is AbbVie a Millionaire Maker?
AbbVie's third-quarter earnings were disappointing, but the company raised its full-year guidance and increased the dividend.
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.
Invest in stocks with good fundamentals, solid growth prospects, and steady dividends. These blue chip stocks have strong businesses that generate consistently strong results.
August 2026 Options Now Available For AbbVie (ABBV)
Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
AbbVie Inc. (NYSE: ABBV) and several other drugmakers are reportedly expected to announce agreements with the U.S. government on Friday to cut select prescription drug prices and comply with addition...
Microsoft, Netflix, Twilio And A Health Care Stock On CNBC's 'Final Trades'
On CNBC's “ Halftime Report Final Trades ,” Virtus Investment Partners’ Joseph M. Terranova named Twilio Inc. (NYSE: TWLO) as his final trade. Lending support to his choice, BTIG analyst Nick Altmann...
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
AbbVie (NYSE: ABBV) has outperformed the market over the past 10 years by 1.89% on an annualized basis producing an average annual return of 14.56%. Currently, AbbVie has a market capitalization of $...
AbbVie, several other pharma companies near MFN deal with Trump, sources say
AbbVie and several other drugmakers are expected to announce on Friday agreements with the U.S. government to lower certain prescription drug prices and meet other demands made by President Donald Tru...
Looking At AbbVie's Recent Unusual Options Activity
Investors with a lot of money to spend have taken a bullish stance on AbbVie (NYSE: ABBV). And retail traders should know. We noticed this today when the trades showed up on publicly available option...
Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc
Market movers: The Investment Committee's top stocks to watch right now.
Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc
Market movers: The Investment Committee’s top stocks to watch right now.
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
AbbVie (ABBV) Gains As Market Dips: What You Should Know
The latest trading day saw AbbVie (ABBV) settling at $227.45, representing a +1.85% change from its previous close.
AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings
Our portfolios underperformed during the quarter and trail year to date. Health care was the primary hindrance as a result of our underweight in biotech and negative stock selection. We have materiall...
My Top 3 Healthcare Stocks to Buy in 2026
With its diverse product line, AbbVie is a terrific dividend stock with a solid underlying business. Eli Lilly is growing its top line incredibly rapidly and expanding into other therapeutic areas.
Morgan Stanley Maintains Overweight Rating on ABBV, Raises Price Target to $269 | ABBV Stock News
Morgan Stanley Maintains Overweight Rating on ABBV, Raises Price Target to $269 | ABBV Stock News
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.
AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock
AbbVie dips below its 50-day SMA, but strong immunology momentum and a resilient long-term trend keep the story compelling.
The Smartest Dividend Stocks to Buy With $5,000 Right Now
Bank of America's low payout ratio means this is a dividend you can count on. AbbVie's raking in money with immunology drugs Skyrizi and Rinvoq.
Hot Picks: Large-cap health care stocks to watch for dividend growth
Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and valuation support.
'This is a great opportunity to get, what we call, a dividend growing stock': Nesbitt on Abbvie Inc.
Don Nesbitt, senior portfolio manager at F/m Investments, joins BNN Bloomberg to share his Hot Picks in healthcare.